A Study to Evaluate the Safety and Clinical Performance of a Dexpanthenol Medicated Hydrogel Patch in the Treatment of Standardized Superficial Abrasions

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-64
SponsorWooshin Labottach Co., Ltd.

About this trial

Clinical evaluation of a Dexpanthenol-medicated wound plaster on standardized superficial skin abrasions

Eligibility criteria

Qualifiers

Healthy male or female volunteers aged 18 to 64 years (inclusive).

Informed consent form signed voluntarily before any study-related procedure.

Subjects willing and able to comply with all study protocol requirements, including scheduled visits and home-wear restrictions.

Intact, healthy skin on both volar forearms (free of tattoos, scars, sunburns, or active skin lesions in the designated test areas).

Disqualifiers

Known hypersensitivity or allergy to Dexpanthenol, hydrogel components, acrylic adhesives, or any component of the investigational devices.

History of keloid formation, hypertrophic scarring, or abnormal wound healing.

Active dermatological conditions (e.g., psoriasis, eczema, atopic dermatitis, active infections) on the upper extremities.

History of diabetes mellitus, peripheral vascular disease, or arterial/venous microangiopathy.

Trial design

Treatments tested in this trial

  • hydrogel plaster with dexpanthenol
  • Standard plaster

Treatment groups

40 Participants
are divided into 3 treatment groups

Sponsors and collaborators

Wooshin Labottach Co., Ltd.

Lead sponsor

Nextrasearch S.r.l.s.

Collaborator